The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 5 , Pages 1115-1122 , November 2009

Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus

  • Thomas Alserius, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery and Anaesthesiology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    • Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    • ,
  • Niklas Hammar, PhD

      Affiliations

    • Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
    • ,
  • Tobias Nordqvist, MSc

      Affiliations

    • Department of Epidemiology, Stockholm Center of Public Health, Karolinska Institute, Stockholm, Sweden
    • ,
  • Torbjörn Ivert, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery and Anaesthesiology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    • Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    • Corresponding Author InformationAddress for reprints: Torbjörn Ivert, MD, PhD, Department of Cardiothoracic Surgery and Anaesthesiology, Karolinska University Hospital, S-171 76 Stockholm, Sweden.

Received 19 November 2008 ,Revised 13 February 2009 ,Accepted 8 March 2009.

References 

  1. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418–423
  2. Schwartz L, Kip KE, Frye RL, Alderman EL, Schaff HV, Detre KM. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 2002;106:2652–2658
  3. Dortimer AC, Shenoy PN, Shiroff RA, Leaman DM, Babb JD, Liedtke AJ, et al. Diffuse coronary artery disease in diabetic patients: fact or fiction?. Circulation. 1978;57:133–136
  4. Ledru F, Ducimetiere P, Battaglia S, Courbon D, Beverelli F, Guize L, et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol. 2001;37:1543–1550
  5. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045–1052
  6. Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, Iaco AL, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg. 2003;125:144–154
  7. Woods SE, Smith JM, Sohail S, Sarah A, Engle A. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: an 8-year prospective cohort study. Chest. 2004;126:1789–1795
  8. Alserius T, Hammar N, Nordqvist T, Ivert T. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J. 2006;152:599–605
  9. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–1021
  10. Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg. 2006;132:802–810
  11. Hakala T, Pitkanen O, Halonen P, Mustonen J, Turpeinen A, Hippelainen M. Early and late outcome after coronary artery bypass surgery in diabetic patients. Scand Cardiovasc J. 2005;39:177–181
  12. Hueb W, Gersh BJ, Costa F, Lopes N, Soares PR, Dutra P, et al. Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease. Ann Thorac Surg. 2007;83:93–99
  13. Kubal C, Srinivasan AK, Grayson AD, Fabri BM, Chalmers JA. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg. 2005;79:1570–1576
  14. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74:712–719
  15. Toumpoulis IK, Anagnostopoulos CE, Balaram SK, Rokkas CK, Swistel DG, Ashton RC, et al. Assessment of independent predictors for long-term mortality between women and men after coronary artery bypass grafting: are women different from men?. J Thorac Cardiovasc Surg. 2006;131:343–351
  16. Mohammadi S, Dagenais F, Mathieu P, Kingma JG, Doyle D, Lopez S, et al. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation. 2007;116:I220–I225
  17. Luciani N, Nasso G, Gaudino M, Abbate A, Glieca F, Alessandrini F, et al. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up. Ann Thorac Surg. 2003;76:1149–1154
  18. Daemen J, Serruys PW. Optimal revascularization strategies for multivessel coronary artery disease. Curr Opin Cardiol. 2006;21:595–601
  19. Cockroft W, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  20. Muller C, Neumann FJ, Ferenc M, Perruchoud AP, Buttner HJ. Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy. Diabetologia. 2004;47:1188–1195
  21. Echahidi N, Pibarot P, Despres JP, Daigle JM, Mohty D, Voisine P, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol. 2007;50:843–851
  22. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001;103:3019–3041
  23. Pell JP, Pell AC, Jeffrey RR, Jennings K, Oldroyd K, Eteiba H, et al. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures. Diabet Med. 2004;21:790–792
  24. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation. 2001;104:533–538
  25. Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 2001;37:1008–1015
  26. Gandjbakhch I, Leprince P, D'Alessandro C, Ouattara A, Bonnet N, Varvous S, et al. [Coronary artery bypass graft surgery in patients with diabetes]. Bull Acad Natl Med. 2005;189:257–267
  27. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA. 2005;293:1501–1508
  28. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(suppl 5):S1–S85
  29. Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation. 2004;110:II41–II44
  30. Anderson RE, Brismar K, Ivert T. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines. Diab Vasc Dis Res. 2007;4:112–116
  31. Anderson RE, Klerdal K, Ivert T, Hammar N, Barr G, Owall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?. Eur Heart J. 2005;26:1513–1518
  32. Estrada CA, Young JA, Nifong LW, Chitwood WR. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75:1392–1399
  33. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006;49:1761–1769
  34. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355:253–259
  35. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005–2016
  36. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854–865
  37. Belcher PR, Gaw A, Cooper M, Brown M, Wheatley DJ, Lindsay GM. Are we negating the benefits of CABG by forgetting secondary prevention?. J Hum Hypertens. 2002;16:691–697

 Supported by the Tornspiran and the Mats Klebergs Foundations and EXPO 95 of the Stockholm County Council.

PII: S0022-5223(09)00423-1

doi: 10.1016/j.jtcvs.2009.03.013

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 5 , Pages 1115-1122 , November 2009

Article Tools

* Image Usage & Resolution